Pharming Group outlines 2025 revenue guidance of $315M to $335M driven by RUCONEST and Joenja growth
Q4 2024 Management View CEO Fabrice Chouraqui highlighted a strong performance in 2024 with revenue growth of 21% to $297 million, exceeding guidance. He emphasized RUCONEST's growth of 11% to $252 ...
PagerDuty outlines $500M-$507M FY2026 revenue target with 7%-8% growth
Q4 2025 Management View CEO Jennifer Tejada highlighted PagerDuty's third consecutive year of non-GAAP profitability, achieving 9% annual growth in both revenue and ARR. Q4 revenue reached $121 ...